Is Merck Stock a Top Buy Right Now? | The Motley Fool
The drugmaker is still a work in progress.
Source: fool.com
Stay updated with breaking news from Return Level. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The drugmaker is still a work in progress.
This blue chip stock illustrates why you should buy and hold quality companies for the long haul.
This REIT has a strong, growing portfolio and long record of dividend payouts that make it a market outperformer.
This company is a key player in renewable energy and has delivered for investors.
These stocks are showing strong revenue and earnings growth, buoyed by healthcare headwinds.